The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus

被引:172
作者
Walsh, TR [1 ]
Howe, RA
机构
[1] Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
[2] Southmead Gen Hosp, Bristol Ctr Antimicrobial Res & Evaluat, Bristol BS10 5NB, Avon, England
关键词
VISA; hVISA; glycopeptide resistance;
D O I
10.1146/annurev.micro.56.012302.160806
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The emergence of Staphylococcus aureus resistant to vancomycin has caused considerable concern. Such strains are currently rare, although they have been isolated from many areas of the world. Considerable controversy surrounds strains of S. aureus displaying heterogeneous resistance to vancomycin regarding their definition and methods for detection. This has led to considerable variance in estimates of prevalence (0-1.3%-20% in Japan) and has hindered efforts to define the clinical relevance of these strains. The mechanism of resistance involves a complex reorganization of cell wall metabolism, leading to a grossly thickened cell wall with reduced peptidoglycan cross-linking. There may be many different ways in which strains achieve this endpoint. Current knowledge and theories are summarized.
引用
收藏
页码:657 / 675
页数:19
相关论文
共 76 条
[1]  
ANDERSON JS, 1967, J BIOL CHEM, V242, P3180
[2]   Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin [J].
Aritaka, N ;
Hanaki, H ;
Cui, LZ ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1292-1294
[3]   Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin [J].
Ariza, J ;
Pujol, M ;
Cabo, J ;
Peña, C ;
Fernández, N ;
Liñares, J ;
Ayats, J ;
Gudiol, F .
LANCET, 1999, 353 (9164) :1587-1588
[4]   Regulation of virulence determinants in Staphylococcus aureus [J].
Arvidson, S ;
Tegmark, K .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 291 (02) :159-170
[5]   Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus [J].
Aucken, HM ;
Warner, M ;
Ganner, M ;
Johnson, AP ;
Richardson, JF ;
Cookson, BD ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :639-640
[6]   Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50 [J].
Avison, MB ;
Bennett, PM ;
Howe, RA ;
Walsh, TR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) :255-260
[8]   The molecular architecture of the sar locus in Staphylococcus aureus [J].
Bayer, MG ;
Heinrichs, JH ;
Cheung, AL .
JOURNAL OF BACTERIOLOGY, 1996, 178 (15) :4563-4570
[9]   DEVELOPMENT OF INVITRO RESISTANCE TO GLYCOPEPTIDE ANTIBIOTICS - ASSESSMENT IN STAPHYLOCOCCI OF DIFFERENT SPECIES [J].
BIAVASCO, F ;
GIOVANETTI, E ;
MONTANARI, MP ;
LUPIDI, R ;
VARALDO, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :71-79
[10]   Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative [J].
Bobin-Dubreux, S ;
Reverdy, ME ;
Nervi, C ;
Rougier, M ;
Bolmström, A ;
Vandenesch, F ;
Etienne, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :349-352